|
09 Jul 2019 |
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
|
|
09 Jul 2019 |
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics
|
|
09 Jul 2019 |
Nimbus Therapeutics and Celgene Expand Alliance to Immunotherapy in Oncology
|
|
09 Jul 2019 |
IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline
|
|
09 Jul 2019 |
ADC Therapeutics Announces Final Close of Series E Financing Expansion
|
|
09 Jul 2019 |
BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline
|
|
09 Jul 2019 |
MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology
|
|
08 Jul 2019 |
Skyhawk Therapeutics Announces Collaboration Agreement with Merck to Discover and Develop Novel Small Molecules that Modulate RNA Splicing
|
|
08 Jul 2019 |
Skyhawk Therapeutics Announces Expansion of Collaboration Agreement with Biogen
|
|
08 Jul 2019 |
Eisai enters into collaboration research agreement with University of Dundee on targeted protein degradation toward cancer drug discovery
|
|
03 Jul 2019 |
Mundipharma announces exclusive license and supply agreement with Prestige Biopharma for Tuznue® (HD201)
|
|
03 Jul 2019 |
New partnership to advance Nosopharm’s lead candidate to clinical stage and develop second drug candidate
|
|
03 Jul 2019 |
Confo Therapeutics and DyNAbind Announce Drug Discovery Collaboration to Identify Novel GPCR-Modulating Compounds
|
|
02 Jul 2019 |
Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform
|
|
01 Jul 2019 |
PTC Therapeutics Announces Strategic Gene Therapy Licensing Agreement with Odylia Therapeutics
|
|
01 Jul 2019 |
Boehringer Ingelheim Expands Nonalcoholic Steatohepatitis (NASH) R&D Pipeline With New First-in-Class Compound from Yuhan Corporation
|
|
01 Jul 2019 |
PeptiDream Announces New Peptide Drug Conjugate (“PDC”) Collaboration Agreement with Novartis
|
|
27 Jun 2019 |
Seelos Therapeutics Announces Acquisition of an Exclusive Worldwide License of Gene Therapy Program to Address Parkinson’s Disease from Duke University
|
|
27 Jun 2019 |
ImmunoGen Announces Completion of Operational Review
|
|
27 Jun 2019 |
OncoSec Receives Exclusive Licensing Rights from Dana-Farber Cancer Institute to CAR T-Cell Therapies for the Treatment of Solid Tumor Cancers
|
|
25 Jun 2019 |
AbbVie to Acquire Allergan in Transformative Move for Both Companies
|
|
25 Jun 2019 |
ERYTECH Announces Immune Modulation Strategic Collaboration with SQZ Biotechnologies
|
|
25 Jun 2019 |
C4X Discovery and PhoreMost collaboration to accelerate Parkinson’s Disease drug discovery pipeline
|
|
25 Jun 2019 |
Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies
|
|
25 Jun 2019 |
Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis
|
